Expanded Access Program for Revumenib

NO_LONGER_AVAILABLE

Conditions studied: Relapsed/Refractory Acute Leukemia

In brief

This expanded access program will provide an investigational treatment option in a controlled clinical setting for participants who are not otherwise eligible to participate in other Syndax-sponsored clinical studies and have no approved treatment options.

Key facts

Study ID

NCT05918913

Run by

Syndax Pharmaceuticals

Last updated by the study team

2025-09-05

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Alabama Center for Childhood Cancer And Blood Disorders, Children's of Alabama — Birmingham, Alabama, United States
• Phoenix Children's Hospital — Phoenix, Arizona, United States
• City of Hope — Duarte, California, United States
• City of Hope at Orange County Lennar Foundation Cancer Center — Irvine, California, United States
• UCLA, UCLA RRMC, Drug Information Center, Department of Pharmaceutical Services Drug Supply Shipment — Los Angeles, California, United States
• Lucile Packard Children's Hospital-Stanford — Palo Alto, California, United States
• Rady Children's Hospital — San Diego, California, United States
• University of California, San Francisco — San Francisco, California, United States
• Center for Cancer and Blood Disorders, Colorado Children's Hospital — Aurora, Colorado, United States
• HCTU, Division of Hematology, University of Colorado, Anschutz Medical Center — Aurora, Colorado, United States
• Advent Health Orlando — Orlando, Florida, United States
• Children's Healthcare of Atlanta — Atlanta, Georgia, United States
• Winship Cancer Institute at Emory University — Atlanta, Georgia, United States
• Lurie Children's Hospital of Chicago — Chicago, Illinois, United States
• University of Chicago Medical Center — Chicago, Illinois, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Children's Hospital — New Orleans, Louisiana, United States
• Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center — Boston, Massachusetts, United States
• Children's Mercy Hospital-Kansas City — Kansas City, Missouri, United States
• Siteman Cancer Center - Washington University — St Louis, Missouri, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• Memorial Sloan Kettering Cancer Center — Long Island City, New York, United States
• Montefiore Medical Center — The Bronx, New York, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.